Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Risk factor thresholds: their existence under scrutiny.

Literature DB >> 12089098

Risk factor thresholds: their existence under scrutiny.

M R Law¹, N J Wald.

Abstract

Mesh：

Substances：
Cholesterol

Year: 2002 PMID： 12089098 PMCID： PMC1123506 DOI： 10.1136/bmj.324.7353.1570

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

45 in total

Review 1. When can a risk factor be used as a worthwhile screening test?

Authors: N J Wald; A K Hackshaw; C D Frost
Journal: BMJ Date: 1999-12-11

2. By how much does dietary salt reduction lower blood pressure? I--Analysis of observational data among populations.

Authors: M R Law; C D Frost; N J Wald
Journal: BMJ Date: 1991-04-06

Review 3. Quantifying the effect of folic acid.

Authors: N J Wald; M R Law; J K Morris; D S Wald
Journal: Lancet Date: 2001-12-15 Impact factor: 79.321

Review 4. Paleolithic nutrition revisited: a twelve-year retrospective on its nature and implications.

Authors: S B Eaton; S B Eaton; M J Konner
Journal: Eur J Clin Nutr Date: 1997-04 Impact factor: 4.016

5. Antecedents of cardiovascular disease in six Solomon Islands societies.

Authors: L B Page; A Damon; R C Moellering
Journal: Circulation Date: 1974-06 Impact factor: 29.690

6. The underlying risk of death after myocardial infarction in the absence of treatment.

Authors: Malcolm R Law; Hilary C Watt; Nicholas J Wald
Journal: Arch Intern Med Date: 2002-11-25

7. Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators.

Authors: F Gueyffier; J P Boissel; F Boutitie; S Pocock; J Coope; J Cutler; T Ekbom; R Fagard; L Friedman; K Kerlikowske; M Perry; R Prineas; E Schron
Journal: Stroke Date: 1997-12 Impact factor: 7.914

8. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors: F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal: N Engl J Med Date: 1996-10-03 Impact factor: 91.245

9. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

Authors:
Journal: Lancet Date: 2001-09-29 Impact factor: 79.321

10. Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia.

Authors: C J Glueck; P Gartside; R W Fallat; J Sielski; P M Steiner
Journal: J Lab Clin Med Date: 1976-12

52 in total

1. Risk factor thresholds. Threshold is 37 000 pounds sterling per QALY.

Authors: Michael A Soljak
Journal: BMJ Date: 2002-11-09

2. A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countries.

Authors: Anthony Rodgers
Journal: BMJ Date: 2003-06-28

Review 3. Cardiology.

Authors: Tom Fahey; Knut Schroeder
Journal: Br J Gen Pract Date: 2004-09 Impact factor: 5.386

Risk factor thresholds: their existence under scrutiny.

Review 1. When can a risk factor be used as a worthwhile screening test?

2. By how much does dietary salt reduction lower blood pressure? I--Analysis of observational data among populations.

Review 3. Quantifying the effect of folic acid.

Review 4. Paleolithic nutrition revisited: a twelve-year retrospective on its nature and implications.

5. Antecedents of cardiovascular disease in six Solomon Islands societies.

6. The underlying risk of death after myocardial infarction in the absence of treatment.

7. Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators.

8. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

9. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

10. Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia.

1. Risk factor thresholds. Threshold is 37 000 pounds sterling per QALY.

2. A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countries.

Review 3. Cardiology.

4. Metabolic cardiovascular risk factors worsen continuously across the spectrum of body mass index in Asian Indians.

5. The polypill: at what price would it become cost effective?

6. Reassessing normal blood pressure.

7. Problems with performance related pay in primary care.

8. Is opportunistic disease prevention in the consultation ethically justifiable?

Review 9. Treatment of multiple-risk patients: using combination therapy to treat beyond LDL lowering.

10. Infectious burden and risk of stroke: the northern Manhattan study.